Keywords: Cancer, Cancer, CEST
Motivation: CEST has a potential to play a complementary role for prediction of postoperative recurrence and improve the prediction capability as compared with DWI, CEST and FDG-PET/CT in NSCLC patients.
Goal(s): The goal was to compare the quantitative prediction capability for postoperative recurrence of FDG-PET/CT and MRI-based molecular information from CEST and DWI in stage I NSCLC patients.
Approach: This clinical study examined CEST imaging, DWI and FDG-PET/CT, and all indexes and combined predictors were compared prediction capabilities in NSCLC.
Results: Specificities and accuracies of MTRasym, ADC and combined predictors were significantly higher than those of SUVmax (p<0.05).
Impact: MRI-based molecular information has better potential for prediction of postoperative recurrence than FDG-PET/CT in stage I NSCLC patients. Moreover, combined CEST and DWI information can improve prediction capability of CEST imaging in this setting.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords